Response on the commentary on “Relevance of cerebral microbleeds with leaky blood brain barrier in traumatic brain injury and protective role of interferon-gamma: a cohort study”
Cerebral Circulation - Cognition and Behavior · 2026 · 10 · 100540
DOI: 10.1016/j.cccb.2026.100540 ↗Kurz gefasst
Leserbrief in der Zeitschrift Cerebral Circulation - Cognition and Behavior, 2026. Verfasst von Xuan Vinh To und 1 weiteren Autor:innen. Beteiligte Einrichtung: Queensland Brain Institute, The University of Queensland, Brisbane, Australia. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Queensland Motor Accident Insurance Commission.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Queensland Brain Institute, The University of Queensland, Brisbane, Australia.
- Centre for Advanced Imaging, The University of Queensland, Brisbane, Australia.
Förderung
- Queensland Motor Accident Insurance Commission
Zitieren
APA
Vinh To, X., & Nasrallah, F. (2026). Response on the commentary on “Relevance of cerebral microbleeds with leaky blood brain barrier in traumatic brain injury and protective role of interferon-gamma: a cohort study”. Cerebral Circulation - Cognition and Behavior, 10, 100540. https://doi.org/10.1016/j.cccb.2026.100540
Vancouver
Vinh To X, Nasrallah F. Response on the commentary on “Relevance of cerebral microbleeds with leaky blood brain barrier in traumatic brain injury and protective role of interferon-gamma: a cohort study”. Cerebral Circulation - Cognition and Behavior. 2026;10:100540. doi:10.1016/j.cccb.2026.100540
BibTeX
@article{VinhTo2026,
author = {Vinh To, Xuan and Nasrallah, Fatima},
title = {Response on the commentary on “Relevance of cerebral microbleeds with leaky blood brain barrier in traumatic brain injury and protective role of interferon-gamma: a cohort study”},
journal = {Cerebral Circulation - Cognition and Behavior},
year = {2026},
volume = {10},
pages = {100540},
doi = {10.1016/j.cccb.2026.100540}
}
EUVIMED